https://www.benzinga.com/pressreleases/20/04/n1592

Quote:

---

SHIRLEY, N.Y., April 30, 2020 /PRNewswire/ -- American Regent, Inc., a top-10 U.S. manufacturer of sterile injectable medicines for over 50 years, is seeking to fill 125 open positions in its New York and Ohio locations. The company is within the designation "essential business" by the governors of New York and Ohio, which enables it to continue producing critical medicines for healthcare providers, clinics and hospitals across the United States. By remaining open, these facilities provide essential medications to critically ill patients, including those with COVID-19. The company's long-term commitment to expanding its U.S.-based manufacturing capabilities creates stable job opportunities for Americans in functions that are important now more than ever.

"Because our manufacturing facilities are U.S.-based and the majority of our active pharmaceutical ingredients and product components are sourced in the U.S., we're able to quickly mobilize, respond to market shortages and sustain production to deliver critical medications for healthcare professionals and the patients who need them," said Ken Keller, President and CEO of American Regent, Inc. "We're proud to be an American manufacturer and have invested over $250 million in our facilities in Ohio and New York to bolster our capabilities. There has never been a greater need for the life-saving medicines that we manufacture than now. It couldn't be a more important time to expand our workforce."

---